[Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy]. 2011

F Roviello, and S Caruso, and D Marrelli, and C Pedrazzani, and A Neri, and A De Stefano, and E Pinto
Universita degli Studi Siena, Policlinico Le Scotte, Dipartimento di Patologia Umana e Oncologia.

Pinto Peritoneal carcinomatosis (PC) had for long been regarded as a terminal disease, characterized by a very poor survival and worthy of being treated with palliative therapy only. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) provide a promising additional treatment option for patients with peritoneal carcinomatosis, resulting in recently published series enable to obtain long-term survival. In spite of the need for more high quality studies, there is now a consensus among many international experts about the use of this new strategy as gold standard for treating with intent of cure selected patients with PC. We summarized the present status and possible future progress of this treatment modality, in particular outlining its rationale, current practice and general outcomes.

UI MeSH Term Description Entries
D006979 Hyperthermia, Induced Abnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation (heat waves, infra-red), ultrasound, or drugs. Fever Therapy,Hyperthermia, Local,Hyperthermia, Therapeutic,Thermotherapy,Induced Hyperthermia,Therapeutic Hyperthermia,Therapy, Fever,Local Hyperthermia
D010478 Chemotherapy, Cancer, Regional Perfusion Neoplasm drug therapy involving an extracorporeal circuit with temporary exclusion of the tumor-bearing area from the general circulation during which high concentrations of the drug are perfused to the isolated part. Cancer Chemotherapy, Regional Perfusion,Perfusion Cancer Chemotherapy, Regional,Regional Perfusion Antineoplastic Chemotherapy,Isolation Perfusion Cancer Chemotherapy,Regional Perfusion Cancer Chemotherapy
D010534 Peritoneal Neoplasms Tumors or cancer of the PERITONEUM. Peritoneal Carcinomatosis,Peritoneal Surface Malignancy,Carcinomatosis, Peritoneal,Malignancy, Peritoneal Surface,Neoplasm, Peritoneal,Peritoneal Carcinomatoses,Peritoneal Neoplasm,Peritoneal Surface Malignancies,Surface Malignancy, Peritoneal
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F Roviello, and S Caruso, and D Marrelli, and C Pedrazzani, and A Neri, and A De Stefano, and E Pinto
November 2007, The Israel Medical Association journal : IMAJ,
F Roviello, and S Caruso, and D Marrelli, and C Pedrazzani, and A Neri, and A De Stefano, and E Pinto
February 2022, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
F Roviello, and S Caruso, and D Marrelli, and C Pedrazzani, and A Neri, and A De Stefano, and E Pinto
June 2016, Revue medicale suisse,
F Roviello, and S Caruso, and D Marrelli, and C Pedrazzani, and A Neri, and A De Stefano, and E Pinto
July 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
F Roviello, and S Caruso, and D Marrelli, and C Pedrazzani, and A Neri, and A De Stefano, and E Pinto
September 2011, Deutsche medizinische Wochenschrift (1946),
F Roviello, and S Caruso, and D Marrelli, and C Pedrazzani, and A Neri, and A De Stefano, and E Pinto
February 2017, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu,
F Roviello, and S Caruso, and D Marrelli, and C Pedrazzani, and A Neri, and A De Stefano, and E Pinto
January 2012, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria,
F Roviello, and S Caruso, and D Marrelli, and C Pedrazzani, and A Neri, and A De Stefano, and E Pinto
April 2013, Annals of surgical oncology,
F Roviello, and S Caruso, and D Marrelli, and C Pedrazzani, and A Neri, and A De Stefano, and E Pinto
January 2016, Cancer control : journal of the Moffitt Cancer Center,
F Roviello, and S Caruso, and D Marrelli, and C Pedrazzani, and A Neri, and A De Stefano, and E Pinto
January 2014, European journal of obstetrics, gynecology, and reproductive biology,
Copied contents to your clipboard!